Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.

Feng J, Yang G, Liu Y, Gao Y, Zhao M, Bu Y, Yuan H, Yuan Y, Yun H, Sun M, Gao H, Zhang S, Liu Z, Yin M, Song X, Miao Z, Lin Z, Zhang X.

Theranostics. 2019 Jul 9;9(18):5227-5245. doi: 10.7150/thno.34273. eCollection 2019.

2.

Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.

Gao Y, Feng J, Yang G, Zhang S, Liu Y, Bu Y, Sun M, Zhao M, Chen F, Zhang W, Ye L, Zhang X.

Hepatology. 2017 Nov;66(5):1413-1429. doi: 10.1002/hep.29316. Epub 2017 Oct 11.

PMID:
28608964
3.

Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.

Liu Y, Feng J, Sun M, Yang G, Yuan H, Wang Y, Bu Y, Zhao M, Zhang S, Zhang X.

Cancer Lett. 2019 Jul 10;454:158-170. doi: 10.1016/j.canlet.2019.04.008. Epub 2019 Apr 11.

PMID:
30981758
4.

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

Dong C, Qu L, Wang H, Wei L, Dong Y, Xiong S.

Antiviral Res. 2015 Jun;118:110-7. doi: 10.1016/j.antiviral.2015.03.015. Epub 2015 Apr 3.

PMID:
25843425
5.

Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, Hösel M, Michler T, Wisskirchen K, Cheng X, Zhang K, Chou WM, Wettengel JM, Malo A, Bohne F, Hoffmann D, Eyer F, Thimme R, Falk CS, Thasler WE, Heikenwalder M, Protzer U.

Gastroenterology. 2016 Jan;150(1):194-205. doi: 10.1053/j.gastro.2015.09.026. Epub 2015 Sep 28.

PMID:
26416327
6.

Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners.

Xu L, Wu Z, Tan S, Wang Z, Lin Q, Li X, Song X, Liu Y, Song Y, Zhang J, Peng J, Gao L, Gong Y, Liang X, Zuo X, Ma C.

Antiviral Res. 2018 May;153:114-123. doi: 10.1016/j.antiviral.2018.03.008. Epub 2018 Mar 23.

PMID:
29580980
7.

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.

Salpini R, Surdo M, Cortese MF, Palumbo GA, Carioti L, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Pasquazzi C, Mirabelli C, Scutari R, Sacco A, Alkhatib M, Missale G, Francioso S, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Levrero M, Perno CF, Belloni L, Svicher V.

Clin Microbiol Infect. 2019 Jul;25(7):906.e1-906.e7. doi: 10.1016/j.cmi.2018.11.017. Epub 2018 Nov 23.

PMID:
30472417
8.

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.

Wei ZQ, Zhang YH, Ke CZ, Chen HX, Ren P, He YL, Hu P, Ma DQ, Luo J, Meng ZJ.

World J Gastroenterol. 2017 Sep 14;23(34):6252-6260. doi: 10.3748/wjg.v23.i34.6252.

9.

Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.

Freitas N, Lukash T, Gunewardena S, Chappell B, Slagle BL, Gudima SO.

J Virol. 2018 Apr 27;92(10). pii: e02221-17. doi: 10.1128/JVI.02221-17. Print 2018 May 15.

10.

DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.

Qi Y, Gao Z, Xu G, Peng B, Liu C, Yan H, Yao Q, Sun G, Liu Y, Tang D, Song Z, He W, Sun Y, Guo JT, Li W.

PLoS Pathog. 2016 Oct 26;12(10):e1005893. doi: 10.1371/journal.ppat.1005893. eCollection 2016 Oct.

11.

Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus.

Kostyushev D, Brezgin S, Kostyusheva A, Zarifyan D, Goptar I, Chulanov V.

Cell Mol Life Sci. 2019 May;76(9):1779-1794. doi: 10.1007/s00018-019-03021-8. Epub 2019 Jan 23.

PMID:
30673820
12.

Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus.

Liu Y, Zhao M, Gong M, Xu Y, Xie C, Deng H, Li X, Wu H, Wang Z.

Antiviral Res. 2018 Apr;152:58-67. doi: 10.1016/j.antiviral.2018.02.011. Epub 2018 Feb 16.

PMID:
29458131
13.

Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma.

Bai F, Yano Y, Fukumoto T, Takebe A, Tanaka M, Kuramitsu K, Anggorowati N, Rinonce HT, Widasari DI, Saito M, Hirano H, Hayakumo T, Seo Y, Azuma T, Ku Y, Hayashi Y.

Int J Hepatol. 2013;2013:849290. doi: 10.1155/2013/849290. Epub 2013 Dec 19.

14.

Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.

Wong DK, Cheng SCY, Lung-Yi Mak L, Wai-Pan To E, Cheuk-Lam Lo R, Cheung TT, Seto WK, Fung J, Man K, Lai CL, Yuen MF.

Clin Gastroenterol Hepatol. 2019 Jun 25. pii: S1542-3565(19)30667-6. doi: 10.1016/j.cgh.2019.06.029. [Epub ahead of print]

PMID:
31252193
15.

SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.

Ren JH, Hu JL, Cheng ST, Yu HB, Wong VKW, Law BYK, Yang YF, Huang Y, Liu Y, Chen WX, Cai XF, Tang H, Hu Y, Zhang WL, Liu X, Long QX, Zhou L, Tao NN, Zhou HZ, Yang QX, Ren F, He L, Gong R, Huang AL, Chen J.

Hepatology. 2018 Oct;68(4):1260-1276. doi: 10.1002/hep.29912. Epub 2018 Jul 25.

PMID:
29624717
16.

PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.

Zhang W, Chen J, Wu M, Zhang X, Zhang M, Yue L, Li Y, Liu J, Li B, Shen F, Wang Y, Bai L, Protzer U, Levrero M, Yuan Z.

Hepatology. 2017 Aug;66(2):398-415. doi: 10.1002/hep.29133. Epub 2017 Jun 19.

PMID:
28236308
17.

HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.

Yan Z, Zeng J, Yu Y, Xiang K, Hu H, Zhou X, Gu L, Wang L, Zhao J, Young JAT, Gao L.

J Hepatol. 2017 Jun;66(6):1149-1157. doi: 10.1016/j.jhep.2017.02.004. Epub 2017 Feb 14.

PMID:
28213165
18.

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.

Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, Levrero M.

Gastroenterology. 2006 Mar;130(3):823-37.

PMID:
16530522
19.

Targeting Hepatitis B Virus With CRISPR/Cas9.

Seeger C, Sohn JA.

Mol Ther Nucleic Acids. 2014 Dec 16;3:e216. doi: 10.1038/mtna.2014.68.

20.

Supplemental Content

Support Center